ClinicalTrials.gov record
Completed Phase 1 Interventional

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

ClinicalTrials.gov ID: NCT00002994

Public ClinicalTrials.gov record NCT00002994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors

Study identification

NCT ID
NCT00002994
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
355 participants

Conditions and interventions

Interventions

  • interleukin 2 Biological
  • rhuMAb Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 1997
Primary completion
Feb 29, 2000
Completion
Mar 31, 2002
Last update posted
Jun 27, 2016

1997 – 2002

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
28
Facility City State ZIP Site status
University of California San Diego Cancer Center La Jolla California 92093-0658
UCSF Cancer Center and Cancer Research Institute San Francisco California 94115-0128
CCOP - Christiana Care Health Services Wilmington Delaware 19899
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140
University of Illinois at Chicago Health Sciences Center Chicago Illinois 60612
University of Chicago Cancer Research Center Chicago Illinois 60637
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201
Dana-Farber Cancer Institute Boston Massachusetts 02115
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203
Barnes-Jewish Hospital St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198-3330
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
Norris Cotton Cancer Center Lebanon New Hampshire 03756
Roswell Park Cancer Institute Buffalo New York 14263-0001
CCOP - North Shore University Hospital Manhasset New York 11030
North Shore University Hospital Manhasset New York 11030
Memorial Sloan-Kettering Cancer Center New York New York 10021
New York Presbyterian Hospital - Cornell Campus New York New York 10021
Mount Sinai Medical Center, NY New York New York 10029
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13210
State University of New York - Upstate Medical University Syracuse New York 13210
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157-1082
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Rhode Island Hospital Providence Rhode Island 02903
Medical University of South Carolina Charleston South Carolina 29425-0721
University of Tennessee, Memphis Cancer Center Memphis Tennessee 38163
Vermont Cancer Center Burlington Vermont 05401-3498

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2016 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002994 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →